Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy

Area of Science:

• Oncology
• Biotechnology
• Nanomedicine

Background:

• Malignant tumors present a significant global health challenge with high mortality rates.
• Conventional cancer treatments like surgery, chemotherapy, and radiotherapy have limitations in efficacy.
• There is an urgent need for innovative and more effective anti-tumor therapeutic strategies.

Purpose of the Study:

• To review the classification and advantages of gene therapies for malignant tumors.
• To discuss the advancements in gene editing technologies for cancer treatment.
• To explore the role of nano-drug delivery systems in enhancing gene editing efficiency.

Main Methods:

• Comprehensive literature review of gene therapy, gene editing, and nanomedicine in oncology.
• Analysis of recent progress in applying gene editing techniques combined with nano-drug delivery for various cancers.
• Evaluation of the prospects and limitations of these advanced therapeutic approaches.

Main Results:

• Gene editing techniques, particularly CRISPR-Cas systems, offer precise genetic modification capabilities for cancer.
• Nano-drug delivery carriers significantly improve the efficiency and targeted delivery of gene editing tools.
• Recent studies demonstrate promising results in treating diverse malignant tumors using this combined approach.

Conclusions:

• The integration of gene editing with nano-drug delivery represents a promising frontier in cancer therapy.
• This strategy enhances therapeutic efficacy and offers potential for overcoming limitations of current treatments.
• Further research is needed to address challenges and fully realize the clinical potential of these techniques.